amodiaquine has been researched along with Parkinson Disease in 1 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, CH | 1 |
Han, BS | 1 |
Moon, J | 1 |
Kim, DJ | 1 |
Shin, J | 1 |
Rajan, S | 1 |
Nguyen, QT | 1 |
Sohn, M | 1 |
Kim, WG | 1 |
Han, M | 1 |
Jeong, I | 1 |
Kim, KS | 2 |
Lee, EH | 1 |
Tu, Y | 1 |
Naffin-Olivos, JL | 1 |
Park, CH | 1 |
Ringe, D | 1 |
Yoon, HS | 1 |
Petsko, GA | 1 |
1 other study available for amodiaquine and Parkinson Disease
Article | Year |
---|---|
Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease.
Topics: Amodiaquine; Animals; Behavior, Animal; Chloroquine; Disease Models, Animal; Ligands; Neurogenesis; | 2015 |